Dr Charles Joseph Musto, DMD | |
920 Wyoming Ave, Ste 104, Forty Fort, PA 18704-3970 | |
(570) 283-3611 | |
(570) 283-3396 |
Full Name | Dr Charles Joseph Musto |
---|---|
Gender | Male |
Speciality | Dentist - Periodontics |
Location | 920 Wyoming Ave, Forty Fort, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417059148 | NPI | - | NPPES |
727338 | Other | PA | PA BLUE SHIELD |
808758 | Other | PA | FIRST PRIORITY HEALTH BC |
727338 | Other | PA | UNITED CONCORDIA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | DP027522A (Pennsylvania) | Secondary |
1223P0300X | Dentist - Periodontics | DS027522L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Charles Joseph Musto, DMD 920 Wyoming Ave Ste 203, Forty Fort, PA 18704-3999 Ph: (570) 283-3611 | Dr Charles Joseph Musto, DMD 920 Wyoming Ave, Ste 104, Forty Fort, PA 18704-3970 Ph: (570) 283-3611 |
News Archive
Thousands of cancer patients in the UK have had their treatment stopped or delayed because of COVID-19, and with pressures mounting on the health service, Cancer Research UK calls for widespread testing to prevent unnecessary cancer deaths.*
Research news published in Criminal Behaviour and Mental Health drew two main findings from a survey of rugby supporters entering and leaving the Millennium Stadium in Cardiff: spectators in the winning and drawing groups rated themselves as more aggressive than those whose team just lost; and more aggressive spectators intended to drink more alcohol after the match.
Want more good hair days? Dermatologists say how you wash your hair and the products you use could go a long way in maintaining smooth, shiny hair.
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced that the Company will present positive data for its NDV-3 vaccine program at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), taking place September 17-20, 2011 in Chicago, IL.
› Verified 6 days ago